Kimberly-Clark's $4 billion international tissue unit set for three-way M&A fight, sources say

Reuters
04/24
UPDATE 1-Kimberly-Clark's $4 billion international tissue unit set for three-way M&A fight, sources say

A deal could fetch around $4 billion, sources say

Bidders expected to submit binding bids by mid-May, sources say

The international business generates around $500 million in annual EBITDA, sources say

Adds background on Vinda acquisition in paragraph 11

By Kane Wu, Yantoultra Ngui and Luciana Magalhaes

HONG KONG/SINGAPORE, April 24 (Reuters) - Southeast Asia's Royal Golden Eagle (RGE) and Asia Pulp & Paper Co $(APP)$, as well as Brazil's Suzano SA SUZB3.SA are the final bidders for Kimberly-Clark's KMB.N international tissue business valued at around $4 billion, four people said.

The three short-listed companies are doing due diligence on the business and are expected to submit binding bids by mid-May, said the people who had knowledge of the matter but did not wish to be identified as the information was not public.

Kleenex tissues maker Kimberly-Clark has hired Goldman Sachs GS.N and Centerview Partners to run the sale of the business, said two of the people.

The unit, which was put on the block by Kimberly-Clark as part of a restructuring initiated last year, generates around $500 million in annual earnings before interest, taxes, depreciation, and amortisation (EBITDA), they said.

Irving, Texas-headquartered Kimberly-Clark did not respond to a request for comment.

Singapore-headquartered resources and energy group Royal Golden Eagle, and Brazilian pulp maker Suzano declined to comment. Indonesia's Asia Pulp & Paper did not respond to a request for comment.

Goldman Sachs and Centerview declined to comment.

The sale is proceeding as U.S. President Donald Trump's broad trade tariffs weigh on Kimberly-Clark's business outlook. The consumer goods company slashed its annual profit forecast on Tuesday due to increased costs as a result of the tariffs.

Its international tissue business, however, will not be similarly impacted, said two of the sources. The business, on the other hand, benefited from the recent depreciation of the U.S. dollar against major currencies around the world, one of the sources added.

RGE is vying for the business as it is planning a major global expansion with potentially billions to spend on acquisitions, said two of the sources.

The group, owned by Indonesian billionaire Sukanto Tanoto, won a bid over APP in 2023 to acquire a 52% stake in Hong Kong-listed tissue and diaper maker Vinda 3331.HK for $3.4 billion. RGE acquired 100% of Vinda in 2024 and took it private.

Suzano, which also participated in Vinda's sale process, told investors last year it would acquire assets to generate growth, according to analysts' reports.

The Brazilian company also engaged in talks in 2024 to buy International Paper IP.N but failed to reach an agreement with the U.S.-based firm, in a deal estimated at about $15 billion.

In 2022 Suzano announced a deal to buy Kimberly-Clark's tissue paper operations in Brazil for an undisclosed sum.

Kimberly-Clark said in March last year that it will reorganise its businesses to simplify operations and cut costs.

(Reporting by Kane Wu in Hong Kong, Yantoultra Ngui in Singapore and Luciana Magalhaes in Sao Paulo; Editing by Muralikumar Anantharaman)

((kane.wu@thomsonreuters.com; +85228436590; Reuters Messaging: kane.wu.thomsonreuters.com@reuters.net))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10